D. Walker et al., Effects of haloperidol pretreatment on the smoking-induced EEG/mood activation response profile, NEUROPSYCHB, 43(2), 2001, pp. 102-112
This study examined the role of dopamine in modulating the CNS response to
cigarette smoking. In a randomized, double-blind, repeated-measures design,
quantitative electroencephalographic (EEG) changes and self-reports induce
d by the smoking of a single cigarette were assessed in 16 smokers followin
g pretreatment with placebo and a dopamine antagonist, haloperidol (2 mg).
Following placebo pretreatment, absolute (muV) and relative (%) amplitudes
in slow-frequency bands (delta, theta, alpha (1)) were reduced and absolute
and relative amplitudes in fast-frequency bands (alpha (2), beta) were inc
reased following cigarette smoking as compared to sham smoking. Haloperidol
pretreatment inhibited the smoking-induced increase in absolute a frequenc
y. Self-ratings indicated that cigarette smoking induced increases in alert
ness, contentedness and calmness but not euphoria, and reduced cigarette cr
avings as compared to the sham smoking conditions. Smoking-induced, alpha (
2) increments were associated with increases in alertness and decreases in
euphoria while beta increments were associated with increased calmness. Smo
king-related self-ratings of mood and cigarette acceptability were not alte
red by haloperidol, but subjects were less content overall in the haloperid
ol condition as compared to placebo. Discussion of these results focuses on
transmitter systems and their relationship to neuro-electric and behaviour
al activities associated with the smoking habit. Copyright (C) 2001 S. Karg
er AG. Basel.